Vaccitech Overview
- Founded
-
2016

- Status
-
Public
- Employees
-
72

- Stock Symbol
-
VACC

- Investments
-
1
- Share Price
-
$5.40
- (As of Thursday Closing)
Vaccitech General Information
Description
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- The Schrodinger Building, Heatley Road
- The Oxford Science Park
- Oxford OX4 4GE
- England, United Kingdom
+44 01865 000000
Vaccitech Timeline
Vaccitech Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$5.40 | $6.21 | $2.97 - $17.99 | $201M | 37.2M | 18.4K | -$1.08 |
Vaccitech Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | (13,002) | 162,293 | ||
Revenue | 15,072 | 268 | 4,821 | 6,845 |
EBITDA | (32,493) | (47,872) | (14,030) | |
Net Income | (33,001) | (50,865) | (17,706) | |
Total Assets | 286,123 | 280,715 | 50,666 | 19,043 |
Total Debt | 6,735 | 7,222 | 46,364 | 1,778 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Vaccitech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Vaccitech Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Vaccitech Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunother
Drug Discovery
Oxford, United Kingdom
72
As of 2021
00000
0000
0000-00-00
00000000
00000
Vaccitech Competitors (63)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | 000 | 000.00 | 00000000 | 000.00 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
00000000 | Venture Capital-Backed | San Carlos, CA | 00 | 00000 | 000000000000 | 00000 |
0000000 0000000000 | Formerly VC-backed | Boston, MA | 0 | 00000 | 000000000 | 00000 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
Vaccitech Patents
Vaccitech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11191825-B2 | Compositions and methods for vaccination against influenza | Active | 16-Sep-2016 | 0000000000 | 0 |
US-20190307877-A1 | Compositions and methods for vaccination against influenza | Granted | 16-Sep-2016 | 000000000 |
Vaccitech Executive Team (8)
Vaccitech Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
Alex Hammacher | Oxford Science Enterprises | Board Member | 000 0000 |
Anne Phillips MD | Vaccitech | Board Member | 000 0000 |
Joseph Scheeren | Vaccitech | Board Member | 000 0000 |
Karen Dawes | Vaccitech | Board Member | 000 0000 |
Pierre Morgon | Self | Board Member | 000 0000 |
Vaccitech Signals
Vaccitech Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Vaccitech Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 10-Dec-2021 | 0000000000 | Biotechnology | 0000000 0 |
Vaccitech Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
000000 00000000000 | Biotechnology | Baltimore, MD | 0000 |